BRIGUGLIO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 121
EU - Europa 120
AS - Asia 26
Totale 267
Nazione #
US - Stati Uniti d'America 121
SE - Svezia 42
IE - Irlanda 34
CN - Cina 23
FR - Francia 10
IT - Italia 9
DE - Germania 7
UA - Ucraina 6
BE - Belgio 5
FI - Finlandia 4
GB - Regno Unito 3
IN - India 3
Totale 267
Città #
Dublin 33
Chandler 25
Nyköping 17
Jacksonville 16
Beijing 14
Ann Arbor 11
Ashburn 10
Brussels 5
Woodbridge 5
Cambridge 4
Medford 4
New York 4
Princeton 4
San Mateo 4
Boardman 3
Pune 3
Des Moines 2
Grammichele 2
Lanzhou 2
Nanchang 2
Taizhou 2
Wilmington 2
Bremen 1
Leawood 1
Los Angeles 1
Ningbo 1
Ratoath 1
Tianjin 1
Zhengzhou 1
Totale 181
Nome #
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 67
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 58
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 53
null 52
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 41
Totale 271
Categoria #
all - tutte 827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 6 2 1 1 2 0 5 7 0 9 10 1
2020/202136 5 0 6 4 2 3 1 0 0 4 8 3
2021/202237 1 4 0 3 0 0 2 2 0 14 2 9
2022/202398 9 12 4 5 6 11 3 3 41 0 4 0
2023/202425 0 4 0 2 2 9 7 0 0 1 0 0
Totale 271